Mustang Bio, Inc. SEC filings MBIO
Mustang Bio, Inc. has 405 filings in SEC EDGAR's recent list, going back to Jul 28, 2016. Its latest annual report, Form 10-K, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Nov 5, 2026 | — |
| 424B5 | Prospectus supplement | Sep 5, 2025 | — |
| POS AM | Filing | Apr 4, 2025 | — |
| 424B3 | Prospectus | Apr 1, 2025 | — |
| 424B3 | Prospectus | Feb 27, 2025 | — |
| 424B3 | Prospectus | Feb 13, 2025 | — |
| 424B4 | Prospectus | Feb 7, 2025 | — |
| S-1/A | Amended registration statement | Feb 5, 2025 | — |
| S-1 | Registration statement | Jan 15, 2025 | — |
| 424B3 | Prospectus | Dec 2, 2024 | — |
| S-3 | Shelf registration | Nov 22, 2024 | — |
| 424B5 | Prospectus supplement | Aug 16, 2024 | — |
| S-1 | Registration statement | Jul 19, 2024 | — |
| 424B5 | Prospectus supplement | Jul 3, 2024 | — |
| 424B5 | Prospectus supplement | Jun 21, 2024 | — |
| 424B5 | Prospectus supplement | Jun 20, 2024 | — |
| S-3 | Shelf registration | May 31, 2024 | — |
| 424B3 | Prospectus | May 13, 2024 | — |
| 424B4 | Prospectus | May 1, 2024 | — |
| S-1/A | Amended registration statement | Apr 29, 2024 | — |
| S-1/A | Amended registration statement | Apr 29, 2024 | — |
| S-1/A | Amended registration statement | Apr 29, 2024 | — |
| S-1/A | Amended registration statement | Apr 2, 2024 | — |
| S-1 | Registration statement | Mar 15, 2024 | — |
| S-1 | Registration statement | Dec 12, 2023 | — |
| 424B5 | Prospectus supplement | Oct 30, 2023 | — |
| S-8 | Employee stock plan registration | Aug 1, 2023 | — |
| 424B5 | Prospectus supplement | Apr 14, 2023 | — |
| S-8 | Employee stock plan registration | Jul 15, 2022 | — |
| S-8 | Employee stock plan registration | Jul 30, 2021 | — |
| S-8 | Employee stock plan registration | Jul 30, 2021 | — |
| S-3/A | Filing | May 20, 2021 | — |
| S-3 | Shelf registration | Apr 23, 2021 | — |
| S-8 | Employee stock plan registration | Apr 2, 2021 | — |
| 424B5 | Prospectus supplement | Dec 31, 2020 | — |
| 424B5 | Prospectus supplement | Dec 4, 2020 | — |
| S-3 | Shelf registration | Oct 23, 2020 | — |
| 424B5 | Prospectus supplement | Jul 20, 2020 | — |
| 424B5 | Prospectus supplement | Jun 12, 2020 | — |
| 424B5 | Prospectus supplement | Jun 10, 2020 | — |
| S-3 | Shelf registration | Aug 16, 2019 | — |
| 424B5 | Prospectus supplement | May 1, 2019 | — |
| 424B5 | Prospectus supplement | Apr 29, 2019 | — |
| 424B5 | Prospectus supplement | Jul 27, 2018 | — |
| S-3/A | Amendment no. 1 to form s-3 | Jul 20, 2018 | — |
| S-3 | Shelf registration | Jul 13, 2018 | — |
| S-8 | Employee stock plan registration | Nov 30, 2017 | — |
Showing 47 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MBIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1680048
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.